Skip to main content

Table 3 Crude and age-adjusted prevalence rates of anti-HEV IgM and anti-HEV IgG among control group, HIV-positive subjects living inside and outside Kathmandu

From: Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal

   HIV (total) Blood donors HIV (Kathmandu) HIV (Outside Kathmandu)
Anti-HEV IgM Crude prevalence rate 15.31 4.64 28.93 4.9
Age adjusted prevalence rate 17.54 3.6 30.61 4.21
Anti-HEV IgG Crude prevalence rate 39.60 9.63 77.8 23.6
Age adjusted prevalence rate 35.02 8.3 65.89 20.84